Previous Close | 23.92 |
Open | 23.90 |
Bid | 23.96 x 1800 |
Ask | 24.79 x 2200 |
Day's Range | 23.85 - 24.20 |
52 Week Range | 21.53 - 33.09 |
Volume | |
Avg. Volume | 966,233 |
Market Cap | 10.508B |
Beta (5Y Monthly) | 0.51 |
PE Ratio (TTM) | 40.02 |
EPS (TTM) | 0.60 |
Earnings Date | N/A |
Forward Dividend & Yield | 0.75 (3.14%) |
Ex-Dividend Date | Apr 01, 2024 |
1y Target Est | 31.50 |
Smith+Nephew (NYSE:SNN; LSE:SN), the global medical technology company is pleased to announce exciting data for its ALLEVYN LIFE Dressing in a recent study by Professor Amit Gefen and his research group published in the International Wound Journal,1 that shows a novel mechanism of action relating to pressure injury prevention (PIP). The study found that due to the independent and non-bonded internal layers of ALLEVYN LIFE Dressing, a layer-on-layer sliding phenomenon occurs and allows for dissip
Compact, single-use, and simple-to-use technology offers surgeons a fast, reliable navigation solution for hip arthroplasty Smith+Nephew (LSE:SN, NYSE:SNN), the global medical technology company, announced an agreement with NAVBIT to exclusively distribute the NAVBIT SPRINT™ in Australia during the recent Australian Orthopedics Association COE Meeting in Sydney. A single-use, sterile navigation system with everything provided in a small carton, NAVBIT SPRINT™ is designed to suit busy surgeons -
Oakmark Funds, advised by Harris Associates, released its “Oakmark International Fund” first quarter 2024 investor letter. A copy of the same can be downloaded here. For the quarter ended March 31, 2024, the fund returned 0.11% compared to the MSCI World ex U.S. Index benchmark’s 5.59% return. Since its inception in September 1992, the fund returned an […]